The total return over the past 12 months is -20.40% vs. +16.94% for the S&P 500. So far it's up -16.38% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (20.40%) | +12.79% | N/A | N/A | N/A | N/A |
| Total Return CAGR | (20.40%) | +12.79% | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Coya Therapeutics, Inc. (COYA)
| Year | Start price | End price | COYA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.80 | $4.85 | (16.38%) | +14.51% | (30.89%) |
| 2025 | $5.73 | $5.80 | +1.22% | +17.72% | (16.50%) |
| 2024 | $7.41 | $5.73 | (22.67%) | +24.89% | (47.56%) |
| 2023 | $4.74 | $7.41 | +56.39% | +26.19% | +30.20% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
